Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Retractable Technologies Inc (RVP)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: RVP (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -21.84% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 18.56M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 1.38 | 52 Weeks Range 0.56 - 1.21 | Updated Date 06/29/2025 |
52 Weeks Range 0.56 - 1.21 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.76 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -67.61% | Operating Margin (TTM) -56.38% |
Management Effectiveness
Return on Assets (TTM) -8.76% | Return on Equity (TTM) -25.89% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -15763612 | Price to Sales(TTM) 0.55 |
Enterprise Value -15763612 | Price to Sales(TTM) 0.55 | ||
Enterprise Value to Revenue 0.14 | Enterprise Value to EBITDA 0.5 | Shares Outstanding 29937200 | Shares Floating 12595461 |
Shares Outstanding 29937200 | Shares Floating 12595461 | ||
Percent Insiders 57.85 | Percent Institutions 7.71 |
Upturn AI SWOT
Retractable Technologies Inc
Company Overview
History and Background
Retractable Technologies, Inc. was founded in 1994. It designs, develops, manufactures, and markets safety medical devices with retractable needles and syringes for the healthcare industry. Its primary focus has been on preventing needlestick injuries and bloodborne infections.
Core Business Areas
- Safety Medical Devices: The company's core business is designing, developing, and manufacturing safety medical devices. These include VanishPointu00ae and EasyPointu00ae retractable needle syringes.
Leadership and Structure
Thomas J. Shaw is the founder, CEO, and President. The company has a typical corporate structure with departments covering R&D, manufacturing, sales, and finance.
Top Products and Market Share
Key Offerings
- VanishPointu00ae Syringes: VanishPointu00ae syringes are automatically retractable syringes designed to prevent needlestick injuries. Market share data is not readily available; however, the product competes with other safety syringes offered by major medical device companies. Competitors include Becton Dickinson, Smiths Medical, and Medtronic. Revenue data specific to this product is not publicly disclosed.
- EasyPointu00ae Needles: EasyPointu00ae needles are retractable needles designed for use with standard syringes, also aimed at reducing needlestick injuries. Market share data is not publicly available. Competitors include Becton Dickinson and other manufacturers of safety-engineered medical devices. Revenue data specific to this product is not publicly disclosed.
Market Dynamics
Industry Overview
The medical device industry is highly competitive and regulated. Demand for safety medical devices is driven by concerns about healthcare worker safety, government regulations (such as the Needlestick Safety and Prevention Act), and the desire to reduce healthcare costs associated with bloodborne infections.
Positioning
Retractable Technologies Inc. is a niche player focused on retractable needle technology. Its competitive advantage lies in its patented technology and specialization in safety syringes and needles.
Total Addressable Market (TAM)
The global safety syringes market is projected to reach billions of USD. Retractable Technologies Inc. has a small share of this TAM, focusing on specific segments and markets.
Upturn SWOT Analysis
Strengths
- Patented retractable needle technology
- Focus on safety
- Strong brand recognition in niche markets
- Cost effective solutions
Weaknesses
- Limited product diversification
- Smaller scale compared to major competitors
- Dependence on specific markets
- Customer concentration
Opportunities
- Expanding into new geographic markets
- Developing new safety medical devices
- Partnering with larger medical device companies
- Increase automation and improve quality control
Threats
- Competition from larger medical device companies
- Price pressure from generic alternatives
- Changes in government regulations
- Risk of obsolescence due to technological advancements
Competitors and Market Share
Key Competitors
- Becton Dickinson (BDX)
- Medtronic (MDT)
- Smiths Medical
Competitive Landscape
Retractable Technologies Inc. competes with larger, more diversified medical device companies. Its advantage lies in its niche focus, but it faces challenges in scaling up and competing on price.
Growth Trajectory and Initiatives
Historical Growth: Historical growth can be assessed by reviewing past annual reports and revenue trends.
Future Projections: Future projections require access to analyst reports and financial models.
Recent Initiatives: Recent initiatives can be found in press releases and investor presentations.
Summary
Retractable Technologies Inc. is a niche player in the safety medical device market with patented technology. Its focus on safety is a strength, but its smaller size and limited diversification pose challenges. The company needs to capitalize on opportunities to expand its market reach and product offerings. Key competitors are Becton Dickinson and Medtronic which have a larger market share of the market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Retractable Technologies Inc. SEC Filings (10-K, 10-Q)
- Company Website
- Market Research Reports
- Analyst Reports
Disclaimers:
This analysis is based on publicly available information and is for informational purposes only. It does not constitute financial advice. Market share estimates are approximate and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Retractable Technologies Inc
Exchange NYSE MKT | Headquaters Little Elm, TX, United States | ||
IPO Launch date 2001-05-04 | Founder, Chairman, President & CEO Mr. Thomas J. Shaw | ||
Sector Healthcare | Industry Medical Instruments & Supplies | Full time employees 221 | Website https://www.retractable.com |
Full time employees 221 | Website https://www.retractable.com | ||
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.